CV Sciences (CVSI) Shares Outstanding (Weighted Average) (2010 - 2026)

CV Sciences has disclosed Shares Outstanding (Weighted Average) across 17 years of filings, most recently posting $186.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $186.9 million, up 1.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $186.9 million (up 1.44% YoY), and the FY2025 annual result was $184.3 million, up 4.94% from the prior year.
• Shares Outstanding (Weighted Average) came in at $186.9 million for Q1 2026 at CV Sciences, up from $184.3 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $186.9 million in Q1 2026 to a low of $10.8 million in Q1 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $153.5 million (2023), against an average of $127.4 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 1324.3% in 2023 and tumbled 92.98% in 2024, its largest moves.
• CV Sciences' Shares Outstanding (Weighted Average) stood at $138.0 million in 2022, then grew by 11.53% to $154.0 million in 2023, then grew by 14.05% to $175.6 million in 2024, then grew by 4.94% to $184.3 million in 2025, then rose by 1.44% to $186.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $186.9 million (Q1 2026), $184.3 million (Q4 2025), and $184.3 million (Q2 2025), per Business Quant data.